EyePoint Pharmaceuticals
EYPT
EYPT
148 hedge funds and large institutions have $988M invested in EyePoint Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% more funds holding
Funds holding: 141 → 148 (+7)
0.49% more ownership
Funds ownership: 100.15% → 100.64% (+0.49%)
7% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 46
Holders
148
Holding in Top 10
5
Calls
$7.54M
Puts
$6.27M
Top Buyers
| 1 | +$28.6M | |
| 2 | +$25.6M | |
| 3 | +$10.8M | |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$9.26M |
| 5 |
Millennium Management
New York
|
+$6.34M |
Top Sellers
| 1 | -$17.7M | |
| 2 | -$8.71M | |
| 3 | -$6.1M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.7M |
| 5 |
BlackRock
New York
|
-$5.63M |
